Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in lung carcinoid patients after receiving curative surgery. A multicentre study
- PMID: 40556676
- PMCID: PMC12185442
- DOI: 10.3389/fonc.2025.1585433
Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in lung carcinoid patients after receiving curative surgery. A multicentre study
Abstract
Background: Recent evidence suggests that inflammation is relevant to carcinogenesis and tumor progression. Biomarkers of the inflammatory response are increasingly regarded as valuable prognostic indicators for enhancing predictive accuracy in non-small cell lung cancer (NSCLC). Nonetheless, the applicability of these measures in patients with pulmonary carcinoid remains uncertain.
Objectives: The primary outcome of this study was to evaluate the prognostic impact on Overall Survival (OS) of the preoperative neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and serum C-reactive protein (CRP) in pulmonary carcinoid after complete surgical resection.
Methods: We retrospectively evaluated data from 267 patients who underwent surgery with curative intent for pulmonary carcinoid tumors between January 2010 and December 2020. Peripheral blood samples were collected preoperatively during routine preoperative tests. The univariable-unadjusted and the Inverse of Probability Weight (IPW) propensity score (PS) adjusted Cox regression models are reported to assess the association between inflammatory biomarkers and outcomes.
Results: The median follow-up duration after surgical resection was four years. Elevated NLR was the only biomarker significantly associated with worse overall survival (OS). The significant association between NLR and OS is evidenced after adjusting for potential confounders using IPW.
Conclusions: This study demonstrated a significant association between the NLR in blood samples of carcinoid patients and their survival outcomes.
Keywords: neutrophil-to-lymphocyte ratio (NLR); non-small cell lung cancer (NSCLC); pulmonary carcinoid; serum c-reactive protein; survival & prognosis.
Copyright © 2025 Tamburini, Aramini, Potenza, Bagolini, Azzolina, Shamshoum, Rea, Stella, Dolci, Pellizzer, Maniscalco and Dell’Amore.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, et al. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol. (2015) 26:1604–20. doi: 10.1093/annonc/mdv041 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous